Hemolysis and hemolytic uremic syndrome following five-fold N-acetylcysteine overdose

Clinical Toxicology

Volumn 49, Issue 8, 2011, Pages 755-759

  Mullins, Michael E ^a   Vitkovitsky, Irena V ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcysteine; Hemolysis; Medication error Overdose; Renal failure

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; AMINOTRANSFERASE; CREATININE; HEMOGLOBIN;

ACETAMINOPHEN POISONING; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD EXAMINATION; CASE REPORT; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HEMATURIA; HEMODIALYSIS; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; LOADING DRUG DOSE; MEDICAL ERROR; PLASMAPHERESIS; SUICIDE ATTEMPT; TERTIARY HEALTH CARE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACETAMINOPHEN; ACETYLCYSTEINE; ACUTE KIDNEY INJURY; ADULT; FEMALE; HEMOLYSIS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MEDICATION ERRORS; POISONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053644694     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2011.609821     Document Type: Article

References (33)

1. Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT. Paracetamol poisoning. Brit Med J 1979; 2:1097-1100.
2. Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol 2009; 47:81-88.
3. Mant TGK, Tempowski JH, Volans GN, Talbot JCC. Adverse reactions to acetylcysteine and effects of overdose. Brit Med J 1984; 289:217-219. (Pubitemid 14014338)
4. Ferner RE, Langford NJ, Anton C, Hutchings A, Bateman DN, Routledge PA. Random and systematic medication errors in routine clinical practice: A multicentre study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol 2001; 52:573-577.
5. Hayes BD, Klein-Schwartz W, Doyon S. Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose. Ann Pharmacother 2008; 42:766-70. (Pubitemid 351778083)
6. Mullins ME, Dribben WH, Halcomb SE, McCammon CA. Reducing dosing errors in IV acetylcysteine for acetaminophen poisoning. Ann Pharmacother 2008; 42:1914-1915.
7. Johnson MT, McCammon CA, Mullins ME, Halcomb SE. Evaluation of a simplifi ed N-acetylcysteine dosing regimen for the treatment of acetaminophen toxicity. Ann Pharmacother 2011; 45:713-720.
8. http://www.clinicaltrials.gov/ct2/archive/NCT01118663 (last accessed Jan 14, 2011
9. Bates DW, Vanderveen T, Seger D, Yamaga C, Rothschild J. Variability in intravenous medication practices: Implications for medication safety. Jt Comm J Qual Pat Saf 2005; 31:203-10.
10. Lesar TS. Errors in the use of medication dosage equations. Arch Pediatr Adolesc Med 1998; 152:340-44. (Pubitemid 28193292)
11. Institute for Safe Medication Practices. Lack of standard dosing methods contributes to IV errors. ISMP Medication Safety Alert! Aug 23, 2007. http://www.ismp.org/Newsletters/acutecare/articles/20070823. asp (accessed Jan 9, 2011
12. Larsen GY, Parker HB, Cash J, O 'C onnell M, Grant MC. Standard drug concentrations and smart-pump technology reduce continuousmedication- infusion errors in pediatric patients. Pediatrics 2005; 116:e21-e25.
13. Bailey B, Blais R, Letarte A. Status epilepticus after a massive intravenous N-Acetylcysteine overdose leading to intracranial hypertension and death. Ann Emerg Med 2004; 44:401-406. (Pubitemid 39237636)
14. Bronstein AC, Spyker DA, Cantilena LR, Green JL, Rumack BH, Giffi n SL. 2008 Annual Report of the American Association of Poison Control Centers ' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol 2009; 47:911-1084.
15. Heard K, Schaeffer TH. Massive acetylcysteine overdose associated with cerebral edema and seizures. Clin Toxicol 2011; 49: 423-425.
16. Levine L, Cowan KM, Osler AG, Mayer MM. Studies on the role of Ca+ and Mg+ in complement fi xation and immune hemolysis: I. Uptake of complement nitrogen by specifi c precipitates and its inhibition by ethylene diamine tetra acetate. J Immunol 1953; 71:359-366.
17. Rapp HJ, Borsos T. Effects of low ionic strength on immune hemolysis. J Immunol 1963; 91:826-832.
18. Schnitzer RJ, Pundsack FL. Asbestos hemolysis. Environ Res 1970; 3:1-13.
19. Becton, Dickinson & Co. BD Vacutainer ® evacuated blood collection system. 11/2010 http://www.bd.com/vacutainer/pdfs/blood-collection- tubes-product-insert-VDP40035.pdf (accessed 28 February 2011
20. Wright RO, Perry HE, Woolf AD, Shannon MW. Hemolysis after acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase defi ciency. J Toxicol Clin Toxicol 1996; 34:731-734. (Pubitemid 27008104)
21. Ruha AM, Selden B, Curry S. Hemolytic anemia after acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase defi-ciency. Am J Med 2001; 110:240-241. (Pubitemid 32155527)
22. Sklar GE. Hemolysis as a potential complication of acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase defi-ciency. Pharmacotherapy 2002; 22:656-658. (Pubitemid 34464956)
23. Korpi-Steiner NL, Hoyne JB, Hoyer JD, Saenger AK. Hemolytic anemia following attempted suicide. Clinical Chemistry 2008; 54:2071-2075.
24. Beutler E. G6PD defi ciency. Blood 1994; 84:3613-3636.
25. Kamerbeek NM, van Zwieten R, de Boer M, Morren G, Vuil H, Bannink N, et al. Molecular basis of glutathione reductase defi ciency in human blood cells. Blood 2007; 109:3560-3566 (Pubitemid 46572550)
26. Caprari P, Caforio MP, Cianciulli P, Maffi D, Pasquino MT, Tarzia A, et al. 6-Phosphogluconate dehydrogenase defi ciency in an Italian family. Ann Hematol 2001; 80:41-44. (Pubitemid 32156763)
27. Szeinberg A, Marks PA. Substances stimulating glucose catabolism by the oxidative reactions of the pentose phosphate pathway in human erythrocytes. J Clin Invest 1961; 40:914-25.
28. Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of trombotic thrombocytopenic purpura. J Am Soc Nephrol 2003; 14:1072-1081.
29. Levy GG, Motto DG, Ginsbure D. ADAMTS 13 turns 3. Blood 2005; 106:11-17.
30. Sadler EJ. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenia purpura. Blood 2008; 112:11-18.
31. Noris M, Remuzzi G. Atypical Hemolytic-Uremic Syndrome. New Engl J Med 2009; 361:1676-1687.
32. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245. (Pubitemid 12149145)
33. Garcia-Cortes M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ, and the Spanish Group for the Study of Drug- Induced Liver Disease. Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of druginduced liver injury. Aliment Pharmacol Ther 2008; 27: 780-789. (Pubitemid 351490076)